|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Julie Phillips, Marketing Manager
Email: julie.phillips@terrapinn.com
Tel: 02075394336
Fax: 02072421508
|
Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries.
Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work
World Scientific Publishing publishes Asia Pacific Biotech News (APBN), the first and only fortnightly report on pharmaceutical, medical, agricultural and environmental sciences in Asia Pacific. APBN is a premium magazine providing industry professionals and experts with breaking news and updates on biotechnology in Asia Pacific. With its rich contents accompanied by insightful and in-depth reports, APBN is widely read by professionals and researchers in the biotechnology sector around the world. Our magazine has a wide reach to the life sciences and biotech community and is present in major conferences in the region. Please visit http://www.asiabiotech.com
About SwissBiotech – One Nation – One Biotech Cluster
SwissBiotech unites the various biotech regions of Switzerland: in a targeted manner, the alliance raises Switzerland's profile as an economic centre abroad and positions its biotech regions as innovative and entrepreneurial focal points of research and production.
Its mission; to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of biotechnology including research, education, economics, finance and industry.
The base for success in Biotechnology is the critical mass of research institutes and rapid Tec transfer. The vicinity to industry and well-trained workforce is another key-driver for success in economy. Recently regions in Switzerland opened a series of ‘Biotech-Parks’ thus enabling to offer ideal geographical placement of companies seeking short distances and increased know-how transfer between universities and industry. State-of-the-art technological infrastructures, productive international human resources and a traditional well publicized quality of life.
The national portal www.swissbiotech.org holds unique information relating to all questions on Biotechnology in Switzerland.
Each year the CTI supports several hundred bottom-up R&D projects, executed in collaboration between companies and non-profit research institutions. It funds the services provided by for example; the Federal Institutes of Technology, conventional universities, and the Universities of Applied Sciences (UAS) etc, paying the salaries of the researchers. Its initiative venturelab has set out to sensitize entrepreneurship in Switzerland by offering various course modules. Furthermore, CTI Start-up promotes the development of new technology-based companies with a high growth potential by providing free professional coaching.
The two main focuses of CTI Life Sciences are biotechnology (CTI Biotech) and medical technology (CTI MedTech).
CTI Life Sciences promotes innovation in these sectors by building bridges between the laboratory and the market; In a CTI Life Sciences project the partnering enterprises benefit from the scientific contributions of the institutes. SMEs with limited research budgets may tap into academic R&D services and infrastructures to bring their innovative products faster to the market. Moreover, CTI Life Sciences funds discovery projects.
The CTI has funded 4,500 projects since 1986. Since 1996, more than 1,000 start-up proposals have been evaluated, with over 120 teams being awarded the prestigious CTI Start-up Label.
London Technology Network (LTN) is funded by the UK Government, the European Union and three Regional Development Agencies (LDA, EEDA and SEEDA) and has the mission to “stimulate the transfer of technology-based innovation”.
LTN links companies worldwide with the technology research base and innovation capacity of the region’s academic and business communities. Since 2002, LTN has recruited a network of research scientists from over 130 leading research departments covering medical/life and computing/physical/engineering sciences and design. This gives LTN knowledge of, and access to, over 6,000 research scientists and their students. LTN works with these scientists, their colleagues and knowledge transfer offices to accelerate knowledge transfer between academia and industry.
LTN also operates the ‘London Innovation Relay Centre’ allowing it to match both innovation supply and innovation demand of London’s companies to partners throughout the EU.
Link to www.ltnetwork.org and www.london-irc.org
Journal of Commercial Biotechnology aims to be the leading publication in its field by increasing practical understanding of the strategic development and management associated with the commercialisation of biotechnology. It seeks to provide a peer-reviewed, international forum for the dissemination and evaluation of the current techniques, strategic thinking and best practice in all aspects of the subject.
Focusing on key strategic insights, in-depth interviews, quick fire Q&A, as well as regular contributions from senior leaders in pharmaceutical manufacturing, this bi-monthly publication is sent to a readership of over 13,000 European professionals. This forward thinking digital publication has a flexible, interactive and user friendly format, allowing readers to access the magazine anytime, anywhere. For more information, contact Simon Percival on T/ +44 (0) 1244 393426, email spercival@advanstar.com or visit our website: www.ptemagazine.com
Pharmaceutical Technology Europe (PTE) magazine is the market-leading publication for European professionals actively involved in pharmaceutical/biopharmaceutical development, manufacturing and QA/QC.Serving the specialist information needs of European R&D and pharmaceutical process professionals, PTE's editorial focuses on new technologies, product developments, critical regulatory issues as well as practical solutions to increase the efficiency and productivity of drug development and production.Every month 18,000 (BPA Audited) professionals depend on PTE to provide them with timely unbiased and essential information on the European pharmaceutical industry.For more information, contact Simon Percival t. +44 (0) 1244 393426 spercival@advanstar.com or visit our website: www.ptemagazine.com
Bio Tech International (BTi) is the only European based publication serving the fields of bioscience and bioindustry. Providing an editorial mix of technology, research, product and industry news, BTi targets both the entrepreneurial life science, bioprocessing and academic research sectors in Europe & Asia/Pacific and offers 100% qualified, BPA-audited circulation. Contact: Shirley Waring
Shirley.Waring@reedbusiness.nl
Drug Delivery Insight: a complete review of the latest commercial and product developments.
Drug Delivery Insight (DDI) takes the hard work out of staying in touch with the companies, products, alliances and research activities shaping the industry. For more information on DDI and to download your free copy visit http://www.espicom.com/ddi
SCREENING - Trends in Drugs Discovery focuses new trends and developments in drug discovery. SCREENING covers all aspects of research as well as strategies of pharmaceutical companies and start-up companies. This editorial mixture makes for relevant reading for all those concerned with drug discovery. SCREENING - Trends in Drugs Discovery is published in English with 4 editions in 2006. For more information please contact Dr. Jutta van Empel at j.empel@gitverlag.com or tel. +49 6151 8090-139.
Thomson Pharma was developed to help pharmaceutical companies make better decisions faster.
It integrates information from Thomson Scientific with information from other Thomson sources, including the Financial, Healthcare and Legal and Regulatory groups. Thomson Pharma's core content areas include drug information, intellectual property data, literature and news, company data, chemical information, sequence data and drug target information, enhanced with value added content resources and powerful search tools. www.thomsonpharma.com
BioPharmaLife-India, the International publication is brought out as a bi-monthly to route the BIOTECH & PHARMA OUTSOURCING activities to India from US and Europe
BioPharmaLife contains up-to-date information on current outsourcing trends in areas of Drug Discovery, Development, Decease Research, Contract Research and manufacturing, Clinical Research, Clinical Trials, BioInformatics and related technology updates covering India, USA, Europe and Asia pacific regions, catering to both the buyers and service providers of Biotech and Pharma outsourcing. It includes in-depth articles, features, interviews, write-ups and extensive coverage of International Biotech & Pharma outsourcing conferences / exhibitions held worldwide.
Issue Highlights include Clinical Trials & Clinical Research market trends, Outsourcing Pharma R & D and manufacturing, Global Healthcare biotech opportunities, The Billion $$$ business of Drug Discovery and lots of Case studies
BIOforum Europe provides the European biotechnology and life sciences markets with everything they need to know about the latest in research and development. It offers a pan-European platform for products and developments and therefore also the possibility of both setting up valuable new customer contacts as well as opening up new possibilities for cooperation. Its high-quality articles from the area of applied research, reports on new methods and applications, interviews, profiles of companies and bio regions, and news reports offer the ideal environment to reach the target customers.
Biopharm International is the #1 magazine devoted to the science, strategies and business trends shaping the global landscape for biotherapeutics. Biopharm's focus on applied technologies utilized in biopharmaceutical development and its focus on the business forces driving the industry's growth has attracted a BPA-qualified, global audience of 29,200.
BioWorld Europe is an innovative magazine for Life Science clusters, commercial and not-for-profit organisations. Its mission is to provide decision-makers in the European biotech industry with thoroughly compiled news, comprehensive background of recent developments, and practical management resources.
BioWorld Europe is pure B2B-communication. It is unique in providing both, an overview on a specific topic – the editorial focus – and in depth coverage on a determined biotech hot spot – the regional focus (see editorial calendar below). Up to two thirds of the magazines total editorial content is dedicated to these specified focus areas.
Thus, current research and technology is related to the people, the organisations and their places. This guarantees for readers, sponsors and advertisers alike that each issue has a high informative value. This value is maximized with an efficiently targeted distribution: each single issue is adjusted to the markets’ needs!
EUROPEAN BIOTECHNOLOGY Science & Industry News:
The attractive information environment of this monthly published magazine constitutes of thoroughly researched news from science and industry, background reports on new EU legislation, current debates and financing initiatives from Brussels, as well as market analyses on the strengths and weaknesses of European biotech nations and previews on upcoming technology trends. With the European Biotechnology News journal you can address a competent an specialized readership in all 25 EU member states, as well as in Switzerland and Norway, predominantly in the major biotech clusters, in renowned European research institutions, as well as the current members of the 13 national scientific and corporate associations and readers in the biotechnology and Life Sciences industry sector.
FierceBiotech is the biotech industry daily monitor covering all aspects of the biotech industry and includes daily biotechnology articles plus a free daily email service covering the biotech industry, with a special focus on human drug development.
FierceBiotech describes all the news about human drug development, including clinical trials info, FDA approvals, scientific breakthroughs, regulations, deals and VC funding, and other biotech industry news for business executives and researchers at small and large companies in the biotech and pharma industries. Learn why more than 40,000 top biotech industry executives rely on FierceBiotech for their daily news. Sign up for your free email at www.fiercebiotech.com
FierceBioResearcher is an easy to read weekly source of biotechnology research news, information and tools, with a special focus on science of drug discovery and development.
FierceBioResearcher will provide you a weekly summary of the latest research breakthroughs, lab tools and technologies, practical tips, case studies and more. Our goal is to save you time and keep you ahead of competition. Join 3,000+ lab research professionals who get FierceBioResearcher via weekly email for their must know updates and news. Sign up for your free weekly email on biotechnology research at www.fiercebioresearcher.com
|
|
|
|
